Cognizant Tech Solutions (CTSH) Holder Bluespruce Investments LP Decreased Its Holding by $2.02 Million as Stock Value Rose; Holder Crestwood Advisors Upped Medtronic Plc Shs (MDT) Position

February 18, 2018 - By Steve Bissell

Crestwood Advisors Llc increased its stake in Medtronic Plc Shs (MDT) by 1.73% based on its latest 2017Q3 regulatory filing with the SEC. Crestwood Advisors Llc bought 4,275 shares as the company’s stock rose 5.51% with the market. The institutional investor held 251,995 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q3, valued at $19.60M, up from 247,720 at the end of the previous reported quarter. Crestwood Advisors Llc who had been investing in Medtronic Plc Shs for a number of months, seems to be bullish on the $112.76 billion market cap company. The stock increased 0.45% or $0.37 during the last trading session, reaching $83.31. About 6.86M shares traded or 28.05% up from the average. Medtronic plc (NYSE:MDT) has risen 4.04% since February 18, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

Bluespruce Investments Lp decreased its stake in Cognizant Tech Solutions (CTSH) by 6.62% based on its latest 2017Q3 regulatory filing with the SEC. Bluespruce Investments Lp sold 28,113 shares as the company’s stock rose 12.87% with the market. The hedge fund held 396,790 shares of the edp services company at the end of 2017Q3, valued at $28.78M, down from 424,903 at the end of the previous reported quarter. Bluespruce Investments Lp who had been investing in Cognizant Tech Solutions for a number of months, seems to be less bullish one the $47.73B market cap company. The stock decreased 0.52% or $0.42 during the last trading session, reaching $80.95. About 4.78 million shares traded or 20.97% up from the average. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has risen 5.50% since February 18, 2017 and is uptrending. It has underperformed by 11.20% the S&P500.

Since August 15, 2017, it had 0 insider purchases, and 37 selling transactions for $59.40 million activity. The insider McLoughlin Karen sold 12,500 shares worth $942,113. 2,358 shares were sold by Shaheen Allen, worth $165,525 on Tuesday, September 5. Mehta Rajeev sold 34,437 shares worth $2.50M. Kandiah Gajakarnan Vibushanan sold $139,248 worth of stock or 1,954 shares. GOMATAM SUMITHRA also sold $576,012 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Monday, September 25. CHATTERJEE DEBASHIS sold $132,902 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Thursday, January 18.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.27, from 0.76 in 2017Q2. It increased, as 37 investors sold CTSH shares while 296 reduced holdings. 99 funds opened positions while 244 raised stakes. 487.81 million shares or 3.03% less from 503.05 million shares in 2017Q2 were reported. Rampart Management Communication invested in 0.2% or 7,995 shares. Linscomb And Williams holds 0.02% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) or 3,830 shares. Levy Harkins And Inc owns 227,294 shares for 5.43% of their portfolio. Norris Perne French Llp Mi has invested 0.09% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Arizona State Retirement System has 0.13% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Ww Asset Mgmt has 57,783 shares. Baystate Wealth Limited Liability Company holds 340 shares or 0% of its portfolio. The Delaware-based Tiverton Asset Management Limited has invested 0.61% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Tdam Usa stated it has 0.04% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Aqr Mngmt Ltd Liability Co holds 0.12% or 1.41 million shares. Badgley Phelps And Bell owns 146,942 shares for 0.79% of their portfolio. 7.42 million were reported by Comgest Glob Invsts Sas. 27,172 are held by Insight Rech And. Japan-based Sumitomo Mitsui Tru has invested 0.17% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Mackenzie Fin Corp reported 0.06% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH).

Among 33 analysts covering Cognizant Technology Solutions Corp. (NASDAQ:CTSH), 25 have Buy rating, 1 Sell and 7 Hold. Therefore 76% are positive. Cognizant Technology Solutions Corp. had 89 analyst reports since August 6, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 3 by RBC Capital Markets. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) earned “Outperform” rating by BMO Capital Markets on Thursday, August 6. Citigroup maintained Cognizant Technology Solutions Corporation (NASDAQ:CTSH) rating on Monday, October 3. Citigroup has “Neutral” rating and $52 target. BMO Capital Markets maintained the stock with “Outperform” rating in Thursday, November 2 report. The firm has “Sell” rating given on Monday, August 10 by Zacks. The company was maintained on Thursday, February 8 by Nomura. Goldman Sachs downgraded the stock to “Neutral” rating in Thursday, September 15 report. The rating was maintained by BMO Capital Markets on Thursday, August 3 with “Buy”. RBC Capital Markets maintained the stock with “Buy” rating in Friday, October 6 report. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has “Buy” rating given on Thursday, August 3 by Oppenheimer.

Bluespruce Investments Lp, which manages about $352.80 million and $530.54M US Long portfolio, upped its stake in Starbucks Corp (NASDAQ:SBUX) by 155,230 shares to 867,279 shares, valued at $46.58 million in 2017Q3, according to the filing. It also increased its holding in Mohawk Industries Inc (NYSE:MHK) by 90,590 shares in the quarter, for a total of 97,952 shares, and has risen its stake in Vantiv Inc (NYSE:VNTV).

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic had 79 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was downgraded by JP Morgan to “Neutral” on Tuesday, January 3. The stock of Medtronic plc (NYSE:MDT) has “Buy” rating given on Friday, May 26 by Oppenheimer. The stock of Medtronic plc (NYSE:MDT) earned “Buy” rating by Needham on Wednesday, August 23. The rating was maintained by Leerink Swann with “Market Perform” on Monday, October 9. Stifel Nicolaus maintained Medtronic plc (NYSE:MDT) on Tuesday, August 22 with “Hold” rating. As per Friday, April 21, the company rating was maintained by Northland Capital. The rating was downgraded by BTIG Research on Wednesday, June 1 to “Neutral”. The rating was initiated by Guggenheim on Thursday, June 9 with “Neutral”. As per Wednesday, November 22, the company rating was maintained by Stifel Nicolaus. The firm earned “Buy” rating on Tuesday, September 22 by UBS.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Steve Bissell

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: